In accordance with the diagnostic recommendations outlined by the European Society for the Study of Coeliac Disease (ESsCD), we stratified our study cohort into three categories based on serological titers of anti-tTG antibodies: <10 U/mL, 10–100 U/mL, and >100 U/mL. Here, TGM2 is linked to celiac disease.